Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic antibodies - natural and pathological barriers and strategies to overcome them.
Al Ojaimi Y, Blin T, Lamamy J, Gracia M, Pitiot A, Denevault-Sabourin C, Joubert N, Pouget JP, Gouilleux-Gruart V, Heuzé-Vourc'h N, Lanznaster D, Poty S, Sécher T. Al Ojaimi Y, et al. Among authors: joubert n. Pharmacol Ther. 2022 May;233:108022. doi: 10.1016/j.pharmthera.2021.108022. Epub 2021 Oct 20. Pharmacol Ther. 2022. PMID: 34687769 Free PMC article. Review.
Antibody-Drug Conjugates: The Last Decade.
Joubert N, Beck A, Dumontet C, Denevault-Sabourin C. Joubert N, et al. Pharmaceuticals (Basel). 2020 Sep 14;13(9):245. doi: 10.3390/ph13090245. Pharmaceuticals (Basel). 2020. PMID: 32937862 Free PMC article. Review.
In Vitro Characterization and Stability Profiles of Antibody-Fluorophore Conjugates Derived from Interchain Cysteine Cross-Linking or Lysine Bioconjugation.
Martin C, Brachet G, Colas C, Allard-Vannier E, Kizlik-Masson C, Esnault C, Respaud R, Denevault-Sabourin C, Chourpa I, Gouilleux-Gruart V, Viaud-Massuard MC, Joubert N. Martin C, et al. Among authors: joubert n. Pharmaceuticals (Basel). 2019 Dec 2;12(4):176. doi: 10.3390/ph12040176. Pharmaceuticals (Basel). 2019. PMID: 31810248 Free PMC article.
Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro.
Aubrey N, Allard-Vannier E, Martin C, Bryden F, Letast S, Colas C, Lakhrif Z, Collinet N, Dimier-Poisson I, Chourpa I, Viaud-Massuard MC, Joubert N. Aubrey N, et al. Among authors: joubert n. Bioconjug Chem. 2018 Nov 21;29(11):3516-3521. doi: 10.1021/acs.bioconjchem.8b00668. Epub 2018 Oct 25. Bioconjug Chem. 2018. PMID: 30352511
54 results